Matthew Tsang

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “Limited antitumor activity of combined BET and MEK inhibition in neuroblastoma”.

Limited antitumor activity of combined BET and MEK inhibition in neuroblastoma

Pediatric Blood & Cancer(2020)10.1002/pbc.28267

N/A

0DataRank · unranked

21 citations

Lori S. Hart, Alexander L. Shazad, Maria Gagliardi, Matthew Tsang, Jimmy Elias +11 more

Testing of B7-H3 targeting antibody-drug conjugate (ADC) MGC018 in models of pediatric solid tumors by the Pediatric Preclinical Testing Consortium (PPTC).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.10037

N/A

0DataRank · unranked

9 citations

Yaël P. Mossé, Vanessa Del Pozo, Eric J. Earley, Stephen W. Erickson, David Groff +9 more

Preclinical Development of [211At]meta- astatobenzylguanidine ([211At]MABG) as an Alpha Particle Radiopharmaceutical Therapy for Neuroblastoma

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-0400

N/A

0DataRank · unranked

31 citations

Minu Samanta, Mehran Makvandi, David Groff, Paul Martorano, Jimmy Elias +11 more

BARD1germline variants induce haploinsufficiency and DNA repair defects in neuroblastoma

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad182

N/A

0DataRank · unranked

25 citations

Laura E. Egolf, Zalman Vaksman, Minu Samanta, Matthew Tsang, David Groff +8 more

A proteogenomic surfaceome study identifies DLK1 as an immunotherapeutic target in neuroblastoma

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.12.06.570390

N/A

0DataRank · unranked

5 citations

Alexander B. Radaoui, Matthew Tsang, Daniel Martínez, Simone Sidoli, Karina L. Conkrite +31 more

BARD1 germline variants induce haploinsufficiency and DNA repair defects in neuroblastoma

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.01.31.525066

N/A

0DataRank · unranked

3 citations

Laura E. Egolf, Zalman Vaksman, Minu Samanta, Matthew Tsang, David Groff +8 more

Data from Preclinical Development of [211At]meta- astatobenzylguanidine ([211At]MABG) as an Alpha Particle Radiopharmaceutical Therapy for Neuroblastoma

(2023)10.1158/1078-0432.c.6532614.v1

N/A

0DataRank · unranked

0 citations

Minu Samanta, Mehran Makvandi, David Groff, Paul Martorano, Jimmy Elias +11 more

A proteogenomic surfaceome study identifies DLK1 as an immunotherapeutic target in neuroblastoma

Cancer Cell(2024)10.1016/j.ccell.2024.10.003

N/A

0DataRank · unranked

18 citations

Alexander B. Radaoui, Matthew Tsang, Daniel Martínez, Karina L. Conkrite, Khushbu Patel +33 more

Lineage-dependence of the neuroblastoma surfaceome defines tumor cell state-dependent and independent immunotherapeutic targets

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.06.27.600865

N/A

0DataRank · unranked

2 citations

Michal Odrobina, Nathaniel W. Mabe, Alvin Farrel, Liron D. Grossmann, Matthew Tsang +9 more

Lineage dependence of the neuroblastoma surfaceome defines tumor cell state-dependent and -independent immunotherapeutic targets

Neuro-Oncology(2025)10.1093/neuonc/noaf012

N/A

0DataRank · unranked

7 citations

Michal Odrobina, Nathaniel W. Mabe, Alvin Farrel, Liron D. Grossmann, Matthew Tsang +10 more

Genome-wide association study of childhood B-cell acute lymphoblastic leukemia reveals novel African ancestry-specific susceptibility loci

Nature Communications(2025)10.1038/s41467-025-64337-7

N/A

0DataRank · unranked

1 citations

Andrew R. Raduski, Lauren J. Mills, Kashi Raj Bhattarai, Robert J. Mobley, Kelly R. Barnett +38 more